FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOb2M0aXZtM3RvVDBpVnc2V3I2ZXpWc2Q3aVJzY3R5OWw3M0NlOEN4cGExc1liYmh4Mkt6TzBrRjh6YTlVT0tFbzk5aFZnRTAxcUxhSWplX0E2aVdBRWt0bVdJNzR4WGFtM2c2Vi1ZdC13R21qOXFNSkVXeXJnaE9FQTFya2pOY0hCZ3dGVXZfQXZHTUxHSG5YaHBpWkxEUjVQdzhJcUxGeFJyRGhwRGtTTXlVcmxvaGZ0bUR2S3NxYlUxNTZCMG5CNzhPY3YzWTQ?oc=5" target="_blank">FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMChina approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMAstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM